Welcome to our dedicated page for CLOUD DX news (Ticker: CDXFF), a resource for investors and traders seeking the latest updates and insights on CLOUD DX stock.
Cloud DX (CDXFF) is a prominent North American digital health platform and provider of remote patient monitoring solutions. The company saw a significant increase in total revenue, subscription revenue, and gross profit in FY2023. Cloud DX offers a Connected Health remote patient monitoring platform that is used by healthcare enterprises to manage chronic diseases, enable aging in place, and deliver post-surgical care at home. The company has secured multiple contracts with provincial health authorities in Canada, including Ontario, Yukon, Prince Edward Island, and British Columbia, highlighting its growing presence in the digital healthcare space.
Cloud DX has secured an 18-month contract with a University School of Nursing in Oregon, becoming the exclusive vendor for Telemedicine and Remote Patient Monitoring equipment. This partnership aims to educate nursing students on advanced virtual care systems. The agreement marks the ninth contract executed by Cloud DX in the first quarter of 2022. Hospitals currently using Cloud DX's Connected Health™ platform report over 95% user satisfaction, showcasing the efficacy of its services in enhancing patient outcomes and healthcare efficiency.
Cloud DX (TSXV:CDX) (OTC:CDXFF) announces a record-setting Q1, having secured over $1.2 million in new contracts and renewals. Key achievements include the signing of its first contract through a partnership with Medtronic for COPD support in Ontario, demonstrating strong patient satisfaction exceeding 95%. Cloud DX aims for significant growth in 2022, anticipating near positive cash flow with the enrollment of approximately 10,000 patients. The success further solidifies its position as a leader in virtual care and remote monitoring for chronic disease management.
Cloud DX (TSXV:CDX) has announced its first joint deployment of Remote Patient Monitoring with Medtronic at St. Mary's General Hospital in Ontario, focusing on a COPD rehabilitation program. The initiative aims to enhance pulmonary care through online therapy sessions and education, demonstrating Cloud DX's growing presence in virtual healthcare. This contract marks a significant step in the partnership, which seeks to improve patient outcomes and reduce hospital burdens, leveraging innovative telehealth solutions.
Cloud DX reported a remarkable 96% patient satisfaction rating from a recent survey at Kingston Health Science Centre. Among the 206 surveyed, 99% expressed willingness to continue home monitoring, indicating the program's effectiveness in empowering patients post-surgery. The findings align with a national clinical study showing reductions in hospital visits and better patient outcomes through virtual care. This success supports Cloud DX's aim to transform healthcare delivery and enhance patient experience, validating their Connected Health™ remote monitoring platform.
Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a North American leader in Virtual Care, has granted 565,363 stock options to consultants and employees as part of a compensation and retention program. The options, with an exercise price of $0.35, will expire on February 15, 2027. Of these, 44,632 options were for company officers. A total of 4,538,490 stock options are now outstanding, with 431,730 Common Shares available for future issuance. Cloud DX aims to improve healthcare delivery through its Connected Health™ platform, recognized with multiple awards.
Equitable Life has partnered with Cloud DX to offer remote patient monitoring services for its critical illness insurance clients, making it the first Canadian insurer to do so. Eligible clients will receive a Cloud DX Connected Health kit and monitoring services covered for up to six months. After this period, continued service will be available for a fee. The initiative aims to improve health outcomes during treatment and recovery for clients facing serious health challenges.
Cloud DX has been recognized as an Innovation Leader in the inaugural New Innovators List by Canadian Business and the Brookfield Institute. Out of 300 applicants, Cloud DX secured a spot in the Top 10 for pushing boundaries in medical device technology and promoting innovation. The company specializes in Connected Health remote patient monitoring, enhancing care across North America. CEO Robert Kaul highlighted their advancements in biomedical hardware and AI-driven technologies, aimed at making healthcare more effective and accessible.
Cloud DX has launched its Cloud XR division, focusing on the Medical Metaverse after six years of development. The new division integrates the award-winning VITALITI™ vital sign monitor with Microsoft's Hololens 2 and Apple's AR app to create a 3D holographic clinical experience. This platform allows clinicians to access patient data and visualize 3D representations remotely, enhancing diagnosis and treatment capabilities. The technology operates hands-free, using voice commands and gestures. The project is supported by multiple patents and prestigious awards, aiming to transform healthcare delivery.
Cloud DX's remote patient monitoring program achieved a 97% satisfaction rate among 204 surveyed patients post-surgery at The Ottawa Hospital. Notably, 89% stated the quality of care was equal to or superior to traditional face-to-face visits. The survey, conducted between May and December 2021, highlighted the program's effectiveness in aiding recovery, with fewer patients requiring hospital readmission. This initiative continues under Ministry of Health funding, with findings supporting enhanced patient outcomes through remote monitoring technology.
Cloud DX Inc. (TSXV:CDX)(OTCQB:CDXFF) announced the completion of the first tranche of its brokered private placement, raising $1,555,000 through the issuance of 1,555 units. Each unit consists of a C$1,000 convertible debenture and 1,430 warrants. The debentures carry an interest rate of 10% and can be converted at C$0.35 per share. The funds will support sales, marketing, R&D, and working capital. Securities issued will be under a four-month hold period until May 28, 2022, pending final approval from the TSX Venture Exchange.
FAQ
What is the current stock price of CLOUD DX (CDXFF)?
What is the market cap of CLOUD DX (CDXFF)?
What is Cloud DX?
What are some key highlights of Cloud DX's performance?
What products does Cloud DX offer?
Which provincial health authorities in Canada has Cloud DX partnered with?